Study links timosaponin AIII to less kidney injury in piglets
Bottom line
A new Frontiers in Veterinary Science study reports that timosaponin AIII, a steroidal saponin derived from Anemarrhena asphodeloides, reduced signs of zearalenone-linked kidney injury in weaned piglets. In the 28-day trial, researchers assigned 18 weaned female piglets to control, zearalenone-only, or zearalenone-plus-timosaponin AIII groups. Piglets exposed to zearalenone at 2 mg/kg had poorer growth, higher serum creatinine and blood urea nitrogen, more renal tissue damage, and more apoptosis, while the group also receiving timosaponin AIII at 20 mg/kg showed significant improvement across those measures. The authors linked the effect to suppression of inflammatory signaling, especially downstream JNK activity within the TLR4/MAPK pathway. (frontiersin.org)
Why it matters: For swine veterinarians and nutrition advisors, the study adds to a growing body of work exploring natural-product strategies to blunt mycotoxin damage when feed contamination occurs. Zearalenone is already well recognized as a major Fusarium mycotoxin in pigs, usually discussed for reproductive effects, but it can also contribute to renal injury and inflammatory stress. This paper is early-stage and experimental, not a field validation or commercial recommendation, but it may widen how veterinary teams think about zearalenone risk, kidney monitoring, and adjunct mitigation beyond binders alone. (frontiersin.org)
What to watch: Whether follow-up studies test timosaponin AIII in larger, mixed-sex, or commercial herd settings, and compare it directly with established mycotoxin-control approaches. (frontiersin.org)
Key facts
- Study type
- 28-day experimental study
- Species
- Weaned female piglets
- Sample size
- 18 piglets
- Groups
- Control, zearalenone-only, and zearalenone-plus-timosaponin AIII
- Zearalenone dose
- 2 mg/kg
- Timosaponin AIII dose
- 20 mg/kg
- Main finding
- Timosaponin AIII improved growth, kidney function markers, renal damage, and apoptosis versus zearalenone alone
- Mechanism
- Suppression of inflammatory signaling, especially JNK in the TLR4/MAPK pathway
- Publication date
- September 30, 2026
A newly published study in Frontiers in Veterinary Science suggests timosaponin AIII may help protect weaned piglets from zearalenone-related kidney injury, adding a renal and inflammatory angle to a mycotoxin more commonly associated with reproductive harm in pigs. The paper, published September 30, 2026, found that piglets receiving timosaponin AIII alongside zearalenone had better growth performance, improved kidney function markers, less histopathologic damage, and less renal apoptosis than piglets exposed to zearalenone alone. (frontiersin.org)
The work fits into a broader push to find practical ways to reduce the impact of feed-borne mycotoxins in swine production. Zearalenone is a Fusarium toxin commonly found in cereals and feed ingredients, and pigs are considered especially sensitive. While field recognition often centers on hyperestrogenism and reproductive losses, prior literature has also described kidney lesions, altered renal biomarkers, and broader inflammatory and oxidative stress effects in pigs and other species. Recent reviews have also highlighted rising interest in natural compounds as potential mitigation tools for zearalenone toxicity. (sciencedirect.com)
In this study, researchers at Henan Agricultural University assigned 18 weaned female piglets to three groups: a basal diet control, a diet with 2 mg/kg zearalenone, and a diet with 2 mg/kg zearalenone plus 20 mg/kg timosaponin AIII for 28 days. Compared with controls, the zearalenone group had lower final body weight, average daily feed intake, and average daily gain, plus higher feed-to-gain ratio, creatinine, blood urea nitrogen, inflammatory cytokines, renal lesions, and TUNEL-positive apoptotic cells. The timosaponin AIII group showed significant improvement in those endpoints. (frontiersin.org)
Mechanistically, the authors focused on TLR4/MAPK signaling. Zearalenone exposure increased renal expression of TLR4, NF-κB, IL-1β, and JNK, while timosaponin AIII was associated with lower IL-1β, JNK, and phosphorylated JNK abundance. The effect did not appear to be a blanket shutdown of the whole pathway: the paper notes that TLR4 protein differences between the zearalenone and treatment groups were not statistically significant, MAP3K7 remained elevated, and IL-1R1 was not restored. That makes the JNK signal especially notable, and suggests a more selective downstream anti-inflammatory effect rather than complete pathway reversal. (frontiersin.org)
Outside this paper, the broader literature supports the basic premise that zearalenone injury may be modifiable, but not yet in a way that gives practitioners a ready-to-use clinical answer. Reviews published in 2025 and 2022 describe a range of natural products under investigation for zearalenone toxicosis, while prior pig and rodent studies have evaluated binders, probiotics, selenium, curcumin, kefir, and other compounds for renal, hepatic, intestinal, or reproductive protection. That context matters because it places timosaponin AIII in a crowded but still largely pre-commercial evidence base. I did not find independent expert commentary on this specific paper yet, which isn't surprising given how recently it was published on September 30, 2026. (frontiersin.org)
Why it matters: For veterinary professionals working with swine herds, the study is less about an immediate treatment change and more about risk framing. It reinforces that zearalenone exposure can affect more than reproduction, and that kidney injury, inflammatory signaling, and growth suppression deserve attention in exposed nursery pigs. It also suggests that mitigation research is moving beyond simple toxin binding toward pathway-targeted nutritional or pharmacologic interventions. Still, this was a small, controlled study in 18 female piglets, with no field conditions, no dose range, no residue or safety discussion for timosaponin AIII, and no comparison against established commercial feed additives. Those limitations should keep the findings in the hypothesis-generating category for now. (frontiersin.org)
For practitioners, the practical takeaway is still feed management first: prevention, surveillance, ingredient quality control, and mycotoxin testing remain the foundation. If a herd has suspected zearalenone exposure, this paper supports watching renal biomarkers and performance impacts alongside the better-known reproductive signs. It may also prompt nutritionists and veterinarians to ask whether future mitigation products should be evaluated for kidney outcomes, not just estrogenic effects or vulvar changes. (pmc.ncbi.nlm.nih.gov)
What to watch: The next meaningful step will be replication in larger and more commercially relevant pig populations, followed by work on dosing, safety, economics, feed-formulation compatibility, and head-to-head comparisons with binders or multi-component mycotoxin programs before timosaponin AIII could move from an interesting mechanism paper to a practical herd-health tool. (ejournals.epublishing.ekt.gr)